Opioid Peptides and Their Pharmacological Effects

Opioid peptides constitute a family of endogenous and synthetic sequences that bind to classical opioid receptors—mu, delta and kappa—and modulate a range of physiological processes. Endogenous members include endorphins, enkephalins, dynorphins and hemorphins, each arising from distinct precursor proteins. Their engagement with G protein-coupled receptors leads to inhibition of adenylate cyclase, modulation of ion channels and downstream signalling pathways that underlie analgesia, mood regulation, stress responses, immune function and gastrointestinal motility. Beyond analgesia, opioid peptides influence cardiovascular homeostasis through interactions with enzymes such as angiotensin-converting enzyme, and they exhibit neuromodulatory roles in memory and learning. Physicochemical properties, including peptide length, sequence modifications and susceptibility to enzymatic degradation, govern bioavailability and half-life, and efforts to improve stability have yielded peptidomimetics with enhanced central nervous system penetration. Recent advances integrate structural biology, computational modelling and pharmacokinetic profiling to guide the rational design of receptor-selective analogues with reduced tolerance and dependence liabilities. The growing toolbox of orthosteric agonists, partial agonists, antagonists and allosteric modulators underscores the translational potential of opioid peptides in pain management, cardiovascular disease and neuropsychiatric disorders.

Research from Nature Portfolio

Recent studies have elucidated how hemorphins interact with angiotensin-converting enzyme homologues at the residue level to reveal conserved and divergent binding modes, guiding the design of domain-specific inhibitors with antihypertensive potential. Computational docking combined with molecular dynamics simulations uncovered key contact points and substrate preferences in both ACE1 and ACE2 catalytic domains. In parallel, multiscale simulations of LVV-hemorphin-7 reveal its high-affinity binding poses across mu-opioid receptors, angiotensin-converting enzyme and insulin-regulated aminopeptidase, with camel-variant sequences displaying enhanced stability and interaction networks. These insights provide a structural framework for exploiting hemorphin variants as multifunctional agents targeting analgesia, blood pressure regulation and cognitive function.

Opioid Peptides and Their Pharmacological Effects publication trend

The graph below shows the total number of articles in opioid peptides and their pharmacological effects across all publications each year (not limited to Nature Index journals).

Technical terms

Opioid peptides: Short amino acid sequences that bind to opioid receptors to modulate pain and other physiological processes.

G protein-coupled receptor (GPCR): A large family of membrane receptors that activate intracellular signalling via G proteins upon ligand binding.

Hemorphins: Endogenous opioid peptides derived from the proteolysis of the hemoglobin β-chain.

Angiotensin-converting enzyme (ACE): A zinc-dependent enzyme that modulates blood pressure by converting angiotensin I to angiotensin II.

Molecular docking: Computational technique that predicts the preferred orientation of a ligand when bound to a protein.

Molecular dynamics simulations: Computational methods that model the time-dependent behaviour of molecular systems at atomic resolution.

References

1. Interaction of hemorphins with ACE homologs. Scientific Reports (2023).
2. Insights into the interaction between hemorphins and δ-opioid receptor from molecular modeling. Frontiers in Molecular Biosciences (2024).
3. Hemorphins Targeting G Protein-Coupled Receptors. Pharmaceuticals (2021).
4. Molecular insights into the interaction of hemorphin and its targets. Scientific Reports (2019).
5. Camel Hemorphins Exhibit a More Potent Angiotensin-I Converting Enzyme Inhibitory Activity than Other Mammalian Hemorphins: An In Silico and In Vitro Study. Biomolecules (2020).
6. Food-Derived Hemorphins Cross Intestinal and Blood–Brain Barriers In Vitro. Frontiers in Endocrinology (2018).
7. Recent Synthesis, Characterization, and Pharmacological Evaluation of Multifunctional Hemorphins Containing Non-Natural Amino Acids with Potential Biological Importance. Pharmaceuticals (2022).